LNWTC
AMGN icon

Laird Norton Wetherby Trust Company’s Amgen AMGN Stock Holding History

Laird Norton Wetherby Trust Company’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.43M Sell
26,809
-449
-2% -$160K 0.21% 74
2025
Q4 		$8.92M Buy
+27,258
New +$8.65M 0.19% 78

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Laird Norton Wetherby Trust Company's AMGN Position: Q1 2026 in Review

Laird Norton Wetherby Trust Company reduced its Amgen (AMGN) stake by 1.6% in Q1 2026, selling an estimated $160K and leaving 26,809 shares worth $9.43M. The position accounts for 0.21% of the portfolio, ranked #74.

Laird Norton Wetherby Trust Company first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Laird Norton Wetherby Trust Company held 26,809 shares of Amgen worth $9.43M as of Q1 2026.
  • Laird Norton Wetherby Trust Company sold 449 Amgen shares in Q1 2026, an estimated $160K.
  • Amgen made up 0.21% of Laird Norton Wetherby Trust Company's portfolio in Q1 2026, its #74 holding.
  • Laird Norton Wetherby Trust Company first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Laird Norton Wetherby Trust Company's 13F filing for Q1 2026, filed 15 May 2026.